Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease
Topic / Pathology
- Parkinson's Disease
Objectives
To have more informations, click on the link below:
https://clinicaltrials.gov/ct2/show/NCT02542696?term=SUNOVION&cond=APL-…
Sponsor
Sunovion
Status
Recruitment completed
